An AI-developed anti-cancer drug has shown effectiveness in human trials for the first time. In 28% of participants who took the maximum oral dose, tumors shrank by more than a third.
Novartis acquires Tourmaline Bio for $1.4 billion, gaining rights to pacibekitug, the first drug that targets the cause of atherosclerosis rather than its effects. This is Novartis' fifth major deal this year. The total value of the agreements has already exceeded $13 billion.
The WHO has added the injectable drug Yeztugo to its recommendations, with a single injection providing HIV prevention for six months. The decision was made against the backdrop of an expected increase in incidence in Africa following a reduction in aid from the US.
The FDA will not restrict the use of mifepristone until there is new evidence of safety concerns, the agency's chief said. At the same time, a large-scale study showed that one in ten American women experienced serious side effects from this abortifacient - 22 times the rate indicated in the labeling.
Eli Lilly will allocate $27 billion for the construction of four manufacturing facilities in the United States. The decision was made after Donald Trump warned about the potential introduction of tariffs on imported drugs for companies without local production.